Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,975,177
+$310,617 QoQ
Shares Held
8,216
+8.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#400
of 1,375 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $69,954,680 across 17 Drug Manufacturers - General names. AMGN ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,352 | $24,410,801 | |
| 2 | ABBV |
AbbVie Inc.
|
52,930 | $13,319,305 | |
| 3 | JNJ |
Johnson & Johnson
|
38,760 | $9,843,877 | |
| 4 | PFE |
Pfizer Inc
|
228,411 | $5,500,136 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,895 | $3,970,007 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
57,120 | $3,291,254 | |
| 7 | AMGN |
Amgen Inc
This page
|
8,216 | $2,975,177 | |
| 8 | NVO |
Novo Nordisk A S
|
30,253 | $1,450,328 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,975,177 | 8,216 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,664,560 | 7,573 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $3,921,173 | 11,980 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,291,181 | 8,119 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $2,064,478 | 7,394 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $2,153,122 | 6,911 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,590,425 | 6,102 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,851,096 | 5,745 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $2,813,924 | 9,006 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,174,525 | 4,131 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $1,151,215 | 3,997 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $1,118,310 | 4,161 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,384,738 | 6,237 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,496,916 | 6,192 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $2,982,802 | 11,357 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,594,128 | 11,509 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,441,272 | 10,034 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $2,426,421 | 10,034 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $1,133,173 | 5,037 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,120,878 | 5,271 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $893,100 | 3,664 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $828,288 | 3,329 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $918,070 | 3,993 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,112,204 | 4,376 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,065,615 | 4,518 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $976,955 | 4,819 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||